1. Home
  2. AGIO vs PRDO Comparison

AGIO vs PRDO Comparison

Compare AGIO & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$40.38

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$36.52

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
PRDO
Founded
2007
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2013
1997

Fundamental Metrics

Financial Performance
Metric
AGIO
PRDO
Price
$40.38
$36.52
Analyst Decision
Buy
Buy
Analyst Count
8
1
Target Price
$38.88
$42.00
AVG Volume (30 Days)
1.2M
662.8K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
1.75%
EPS Growth
N/A
10.50
EPS
N/A
0.85
Revenue
$43,011,000.00
$581,296,000.00
Revenue This Year
$76.75
$4.28
Revenue Next Year
$170.73
$2.89
P/E Ratio
N/A
$42.01
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$26.66
52 Week High
$46.00
$38.50

Technical Indicators

Market Signals
Indicator
AGIO
PRDO
Relative Strength Index (RSI) 65.36 68.15
Support Level $39.31 $34.13
Resistance Level $43.72 $36.90
Average True Range (ATR) 1.76 1.05
MACD 0.30 0.41
Stochastic Oscillator 60.73 97.74

Price Performance

Historical Comparison
AGIO
PRDO

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

Share on Social Networks: